The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Adrenal incidentalomas: A manifestation of the metabolic syndrome?
Abstract
Recent evidence suggests that insulin is mitogenic on the adrenal cortex and stimulates adrenocortical tumor formation. We, investigated whether hyperinsulinemia is present in 13 patients with incidentally detected adrenal tumors. Patients with adrenal incidentalomas were obese (mean BMI 29.7 +/- 1.2 kg/m2, normal < 25; % body fat 35 +/- 1.5%, normal < 30%) with increased abdominal fat deposition (waist to hip ratio 0.92 +/- 0.02, normal < 0.85). All 13 patients were insulin resistant. Five had NIDDM, of the remaining patients 5 had fasting insulin concentrations above 15 microE/ml, and all 8 patients had elevated insulin concentrations after 75 g of glucose orally. To further investigate the potential role of insulin we examined its effects on the NCI-h295 cell line. Insulin (1-100 micrograms/ml) stimulated cell proliferation in a time and dose-dependent matter without affecting cortisol synthesis. At this concentrations insulin was equally potent to IGF I (10-80 ng/ml) or IGF II (10-100 ng/ml). We conclude that the majority of patients with adrenal incidentalomas are insulin-resistant/hyperinsulinemic. Insulin stimulates adrenal cancer cell lines in vitro. We propose that adrenal incidentalomas are a newly recognized manifestation of the metabolic syndrome comparable to insulin-mediated stimulation of the ovary in the polycystic ovary syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Despite the absence of florid signs and symptoms, ACS in patients AI has been associated with hypertension (215), insulin resistance (216), type 2 diabetes mellitus (217), obesity (218), metabolic syndrome (219), and increased mortality (75).”
From Adrenal incidentaloma (2020) · cites this paper as [216]
In the citing paper
“In fact, it has been demonstrated that insulin is mitogenic, capable of stimulating adrenal cortex cell proliferation and tumor formation in a time-and dose-dependent manner, without affecting cortisol synthesis (, ).”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [218]
Citations
Cites
Gicquel, C., BERTAGNA, X. Y., Schneid, H., Leblond‐Francillard, M., LUTON, J. P., Girard, F., & Bouc, Y. L. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.6.7911125 · Cited by 224
Ilvesmäki, V., Kahri, A. I., Miettinen, P. J., & Voutilainen, R. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.3.8370710 · Cited by 152
Mesiano, S., Mellon, S. H., & Jaffe, R. B. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.4.8473412 · Cited by 135
PENHOAT, A., CHATELAIN, P. G., JAILLARD, C., & SAEZ, J. M. (1988) · Endocrinology · doi:10.1210/endo-122-6-2518 · Cited by 127
Kamio, T., Shigematsu, K., Kawai, K., & Tsuchiyama, H. (1991) · PubMed Central · Cited by 57
Receptors for insulin and insulin-like growth factor-I in the human adrenal gland
Pillion, D. J., Arnold, P., Yang, M., Stockard, C. R., & Grizzle, W. E. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91055-3 · Cited by 47
Bondy, C. A., Zhou, J., Chin, E., Reinhardt, R., Li, D., & Roth, R. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117103 · Cited by 43
Naaman, E., Chatelain, P., Saez, J. M., & Durand, P. (1989) · Biology of Reproduction · doi:10.1095/biolreprod40.3.570 · Cited by 36
Research works printed but not linked: 5
- Reincke M, 1995, Dtsch Ärzteblatt, 92, 764
- Ilvesmäki V, 1993, J Clin Endocrinol Metab, 77, 852
- Giquel C, 1994, J Clin Endocrinol Metab, 78, 1444
- Mesiano S, 1993, J Clin Endocrinol Metab, 76, 968
- Kamio T, 1991, Am J Pathol, 138, 83
Cited by
Sorted by citations
Fassnacht, M., Arlt, W., Bancos, I., Dralle, H., Newell-Price, J., Sahdev, A., Tabarin, A., Terzolo, M., Tsagarakis, S., & Dekkers, O. M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0467 · Cited by 1,566
Faßnacht, M., Tsagarakis, S., Terzolo, M., Tabarin, A., Sahdev, A., Newell-Price, J. D. C., Pelsma, I. C. M., Marina, L., Lorenz, K., Bancos, I., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad066 · Cited by 849
Adrenocortical Carcinoma: Clinical Update
Allolio, B., & Fassnacht, M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2639 · Cited by 775
Prevalence and natural history of adrenal incidentalomas
Barzon, L., Sonino, N., Fallo, F., Palu, G., & Boscaro, M. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490273 · Cited by 642
AME Position Statement on adrenal incidentaloma
Terzolo, M., Stigliano, A., Chiodini, I., Loli, P., Furlani, L., Arnaldi, G., Reimondo, G., Pia, A., Toscano, V., Zini, M., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1147 · Cited by 523
Sherlock, M., Scarsbrook, A., Abbas, A., Fraser, S., Limumpornpetch, P., Dineen, R., & Stewart, P. M. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa008 · Cited by 347
“Despite the absence of florid signs and symptoms, ACS in patients AI has been associated with hypertension (215), insulin resistance (216), type 2 diabetes mellitus (217), obesity (218), metabolic syndrome (219), and increased mortality (75).”
BackgroundAdrenal incidentaloma: a new cause of the metabolic syndrome?
Terzolo, M., Pia, A., Alì, A., Osella, G., Reimondo, G., Bovio, S., Daffara, F., Procopio, M., Paccotti, P., Borretta, G., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8277 · Cited by 322
Risk Factors and Long-Term Follow-Up of Adrenal Incidentalomas1
Barzon, L., Scaroni, C. M., Sonino, N., Fallo, F., Paoletta, A., & Boscaro, M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5444 · Cited by 255
Chiodini, I., Torlontano, M., Scillitani, A., Arosio, M., Bacci, S., Di Lembo, S., Epaminonda, P., Augello, G., Enrini, R., Ambrosi, B., et al. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02045 · Cited by 190
Metabolic comorbidities in Cushing's syndrome
Ferraù, F., & Korbonits, M. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0354 · Cited by 226
Subclinical Cushing’s syndrome in adrenal incidentalomas
Terzolo, M., Bovio, S., Reimondo, G., Pia, A., Osella, G., Borretta, G., & Angeli, A. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.01.008 · Cited by 179
Charmandari, E., Weise, M., Bornstein, S. R., Eisenhofer, G., Keil, M. F., Chrousos, G. P., & Merke, D. P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8456 · Cited by 164
OVARIAN AND ADRENAL FUNCTION IN POLYCYSTIC OVARY SYNDROME
Rosenfield, R. L. (1999) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70070-0 · Cited by 164
Adrenal Incidentalomas are Tied to Increased Risk of Diabetes: Findings from a Prospective Study
Reimondo, G., Castellano, E., Grosso, M., Priotto, R., Puglisi, S., Pia, A. R., Pellegrino, M., Borretta, G., & Terzolo, M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz284 · Cited by 149
Diagnosis and differential diagnosis of Cushing’s syndrome
Findling, J. W., & Raff, H. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70209-7 · Cited by 147
Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management
Scaroni, C., Zilio, M., Foti, M., & Boscaro, M. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1105 · Cited by 140
The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection
Midorikawa, S., Sanada, H., Hashimoto, S., Suzuki, T., & Watanabe, T. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01274.x · Cited by 134
Pelsma, I. C. M., Fassnacht, M., Tsagarakis, S., Terzolo, M., Tabarin, A., Sahdev, A., Newell-Price, J., Marina, L., Lorenz, K., Bancos, I., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad134 · Cited by 130
Skeletal Muscle Insulin Resistance in Endocrine Disease
Peppa, Μ., Koliaki, C. C., Nikolopoulos, P., & Raptis, S. (2010) · BioMed Research International · doi:10.1155/2010/527850 · Cited by 129
Body Composition and Metabolic Features in Women with Adrenal Incidentaloma or Cushing's Syndrome
Garrapa, G., Pantanetti, P., Arnaldi, G., Mantero, F., & Faloia, E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.11.8059 · Cited by 132
Mild autonomous cortisol secretion: pathophysiology, comorbidities and management approaches
Prete, A., & Bancos, I. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-00984-y · Cited by 130
Management of adrenal incidentaloma
Terzolo, M., Bovio, S., Pia, A., Reimondo, G., & Angeli, A. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.04.001 · Cited by 113
Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours
Fernández‐Real, J. M., Ricart Engel, W., Simó, R., Salinas, I., Webb, S. M., & and the Study Group of Incidental Adrenal Adenoma (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00437.x · Cited by 109
Bernini, G., Moretti, A., Iacconi, P., Miccoli, P., Nami, R., Lucani, B., & Salvetti, A. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480213 · Cited by 105
Glucocorticoids and neuroendocrine function
Cavagnini, F., Croci, M., Putignano, P., Petroni, M. L., & Invitti, C. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801284 · Cited by 105
Giordano, R., Marinazzo, E., Berardelli, R., Picu, A., Maccario, M., Ghigo, E., & Arvat, E. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0957 · Cited by 99
Peppa, Μ., Boutati, E. I., Koliaki, C. C., Papaefstathiou, N., Garoflos, E., Economopoulos, T., Hadjidakis, D., & Raptis, S. (2010) · Metabolism · doi:10.1016/j.metabol.2010.01.007 · Cited by 89
Sereg, M., Szappanos, Á., Tőke, J., Karlinger, K., Feldman, K., Kaszper, É., Varga, I., Gláz, E., Rácz, K., & Tóth, M. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0707 · Cited by 81
Subclinical Cushing's syndrome.
Terzolo, M., Reimondo, G., Bovio, S., & Angeli, A. (2004) · Pituitary · doi:10.1007/s11102-005-4024-6 · Cited by 80
Tsagarakis, S., Roboti, C., Kokkoris, P., Vasiliou, V., Alevizaki, C., & Thalassinos, N. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00509.x · Cited by 75
Faßnacht, M., Hahner, S., Hansen, I. A., Kreutzberger, T., Zink, M., Adermann, K., Jakob, F. J., Troppmair, J., & Allolio, B. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021318 · Cited by 68
Subclinical Cushing's syndrome
Terzolo, M., Bovio, S., Pia, A. R., Osella, G., Borretta, G., Angeli, A., & Reimondo, G. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000800013 · Cited by 67
Tuna, M. M., İmga, N. N., Dogan, B. A., Yılmaz, F. M., Topçuoğlu, C., Akbaba, G., Berker, D. S., & Güler, S. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0106-5 · Cited by 66
Adipose Tissue and Adrenal Glands: Novel Pathophysiological Mechanisms and Clinical Applications
Kargi, A. Y., & Iacobellis, G. (2014) · International Journal of Endocrinology · doi:10.1155/2014/614074 · Cited by 63
Glucose metabolism in patients with subclinical Cushing’s syndrome
Giordano, R., Guaraldi, F., Berardelli, R., Karamouzis, I., D’Angelo, V., Marinazzo, E., Picu, A., Ghigo, E., & Arvat, E. (2012) · Endocrine · doi:10.1007/s12020-012-9628-9 · Cited by 64
Subclinical Cushing’s syndrome
Leo, M. D., Cozzolino, A., Colao, A. A. L., & Pivonello, R. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2012.02.001 · Cited by 65
Vassiliadi, D. A., Ntali, G., Vicha, E., & Tsagarakis, S. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03963.x · Cited by 61
The clinical significance of adrenal incidentalomas
Androulakis, I. I., Kaltsas, G., Piaditis, G. P., & Grossman, A. B. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02436.x · Cited by 61
Muscogiuri, G., Sorice, G. P., Prioletta, A., Mezza, T., Cipolla, C., Salomone, E., Giaccari, A., Pontecorvi, A., & Della Casa, S. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03928.x · Cited by 52
New mechanisms of adrenostatic compounds in a human adrenocortical cancer cell line
Faßnacht, M., Hahner, S., Beuschlein, F., Klink, A., Reincke, M., & Allolio, B. (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.0300s3076.x · Cited by 52
Adrenal Incidentaloma—A Modern Disease with Old Complications
Angeli, A., & Terzolo, M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021436 · Cited by 47
Tsatsoulis, A. A. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7030037 · Cited by 48
Peppa, Μ., Koliaki, C. C., & Raptis, S. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02291.x · Cited by 44
Adrenocortical tumors and insulin resistance: What is the first step?
Altieri, B., Tirabassi, G., Casa, S. D., Ronchi, C. L., Balercia, G., Orio, F., Pontecorvi, A., Colao, A., & Muscogiuri, G. (2015) · International Journal of Cancer · doi:10.1002/ijc.29950 · Cited by 39
Godoy‐Matos, A. F., Vieira, A. R., Moreira, R. O., Coutinho, W. F., Carraro, L., Moreira, D. M., Pasquali, R., & Meirelles, R. M. R. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03344090 · Cited by 38
Cardiovascular Risk in Patients with Nonfunctional Adrenal Incidentaloma: Myth or Reality?
Erbil, Y., Özbey, N., Barbaros, U., Ünalp, H. R., Salmaslıoğlu, A., & Özarmağan, S. (2009) · World Journal of Surgery · doi:10.1007/s00268-009-0178-0 · Cited by 37
Subclinical Cushing’s syndrome: Current concepts and trends
Zografos, G. N., Perysinakis, I., & Vassilatou, E. (2014) · HORMONES · doi:10.14310/horm.2002.1506 · Cited by 33
Faßnacht, M., Beuschlein, F., Vay, S., Mora, P., Allolio, B., & Reincke, M. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1590035 · Cited by 34
The Insulin and IGF-I Pathway in Endocrine Glands Carcinogenesis
Malaguarnera, R., Morcavallo, A., & Belfiore, A. (2012) · Journal of Oncology · doi:10.1155/2012/635614 · Cited by 33
Midorikawa, S., Sanada, H., Hashimoto, S., Suzuki, T., Watanabe, T., & Sasano, H. (2001) · Endocrine Journal · doi:10.1507/endocrj.48.167 · Cited by 31
Charmandari, E. (2002) · Archives of Disease in Childhood · doi:10.1136/adc.86.4.266 · Cited by 30
Possible, probable, and certain hypercortisolism: A continuum in the risk of comorbidity
Castro, M. A., Corrales, E. P., & Lamas, C. (2023) · Annales d Endocrinologie · doi:10.1016/j.ando.2023.01.005 · Cited by 36
MANAGEMENT APPROACHES TO ADRENAL INCIDENTALOMAS (ADRENALOMAS)
Linos, D. A. (2000) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70121-3 · Cited by 29
AGE-RELATED ENDOCRINE TUMORS: NON-FUNCTIONINGADRENAL TUMORS AS COMPARED TO PITUITARYADENOMAS
Gheorghiu, M. L. (2009) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2009.371 · Cited by 28
Shariq, O. A., Fruth, K. M., Hanson, K. T., Cronin, P. A., Richards, M. L., Farley, D. R., Thompson, G. B., Habermann, E. B., & McKenzie, T. J. (2017) · Surgery · doi:10.1016/j.surg.2017.06.023 · Cited by 28
Nonfunctioning Adrenal Incidentalomas are not Clinically Silent: A Longitudinal Cohort Study
Kim, J. H., Kim, M. J., Lee, J. H., Yoon, J. W., & Shin, C. S. (2020) · Endocrine Practice · doi:10.4158/ep-2020-0182 · Cited by 27
The role of insulin-like growth factor system in the adrenocortical tumors
Altieri, B., Colao, A., & Faggiano, A. (2018) · Minerva Endocrinology · doi:10.23736/s0391-1977.18.02882-1 · Cited by 27
Faloia, E., Giacchetti, G., & Mantero, F. (2000) · Journal of Endocrinological Investigation · doi:10.1007/bf03343677 · Cited by 26
Podbregar, A., Janež, A., Goričar, K., & Jensterle, M. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00599-0 · Cited by 25
Emral, R., Aydoğan, B. İ., Köse, A. D., Demir, Ö., & Çorapçıoğlu, D. (2019) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2019.01.007 · Cited by 24
Cortisol: Mediator of association between Alzheimer’s disease and diabetes mellitus?
Notarianni, E. L. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.04.008 · Cited by 23
Insulin resistance and adrenal incidentalomas: A bidirectional relationship
Sydney, G. I., Ioakim, K. J., & Paschou, S. Α. (2018) · Maturitas · doi:10.1016/j.maturitas.2018.12.002 · Cited by 23
Imga, N. N., Elalmış, Ö. U., Tuna, M. M., Dogan, B. A., Şahin, D., Berker, D. S., & Güler, S. (2016) · Intern J Endocrinol Metab · doi:10.5812/ijem.37635 · Cited by 22
Incidental and Metastatic Adrenal Masses
Mannelli, M., Colagrande, S., Valeri, A., & Parenti, G. (2010) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.10.018 · Cited by 20
Walzer, D., Turcu, A. F., Jha, S., Abel, B. S., Auchus, R. J., Merke, D. P., & Brown, R. J. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac365 · Cited by 22
Castro, M. A. (2022) · Clinical Endocrinology · doi:10.1111/cen.14745 · Cited by 20
Comorbidities in Mild Autonomous Cortisol Secretion – A Clinical Review of Literature
Czapla-Iskrzycka, A., Świątkowska−Stodulska, R., & Sworczak, K. (2022) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1827-4113 · Cited by 20
Adrenal morpho-functional alterations in patients with acromegaly
Scaroni, C. M., Selice, R., Benedini, S., Menis, E. D., Arosio, M., Ronchi, C. L., Gasperi, M., Manetti, L., Arnaldi, G., Polenta, B., et al. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03345609 · Cited by 20
Khan, U. (2019) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_52_19 · Cited by 20
Ioakim, K. J., Sydney, G. I., & Paschou, S. Α. (2019) · HORMONES · doi:10.1007/s42000-019-00147-z · Cited by 19
Adrenal Mass: Insight Into Pathogenesis and a Common Link With Insulin Resistance
Muscogiuri, G., Martino, M. C. D., Negri, M., Pivonello, C., Simeoli, C., Orio, F., Pivonello, R., & Colao, A. A. L. (2017) · Endocrinology · doi:10.1210/en.2016-1804 · Cited by 18
Two-year follow-up of thirty-two non-functional benign adrenal incidentalomas
Yılmaz, H., Tütüncü, N. B., & Şahi̇n, M. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345772 · Cited by 18
Issa, B. G., Hanna, F., Fryer, A. A., Ensah, G., Ebere, I., Marshall, D., & Keevil, B. G. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad242 · Cited by 17
Marina, L., Ivović, M., Tančić‐Gajić, M., Arizanović, Z., Raković, D., Milin-Lazovic, J. S., Kendereški, A., Micić, D., & Vujović, S. (2017) · Clinical Endocrinology · doi:10.1111/cen.13541 · Cited by 17
Nonalcoholic fatty liver disease in subjects with adrenal incidentaloma
Papanastasiou, L., Παππά, Θ., Samara, C., Apostolopoulou, G., Tsiavos, V., Markou, Α., Alexandraki, K., Piaditis, G. P., Chrousos, G. P., & Kaltsas, G. (2012) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2012.02707.x · Cited by 17
Delibaşı, T., Karbek, B., Bozkurt, N. Ç., Çakır, E., Güngüneş, A., Ünsal, Ö. Ö., Aslan, M. S., & Çakal, E. (2015) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000053 · Cited by 15
Adrenal incidentaloma: cardiovascular and metabolic effects of mild cortisol excess
Kelsall, A., Iqbal, A., & Newell-Price, J. D. C. (2020) · Gland Surgery · doi:10.21037/gs.2019.11.19 · Cited by 15
Kong, S. H., Kim, J. H., & Shin, C. S. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0301 · Cited by 14
Markers of Subclinical Cardiovascular Disease in Patients with Adrenal Incidentaloma
Szychlińska, M., Baranowska-Jurkun, A., Matuszewski, W., Wołos-Kłosowicz, K., & Bandurska-Stankiewicz, E. M. (2020) · Medicina · doi:10.3390/medicina56020069 · Cited by 14
Prevalence of adrenal masses in Japanese patients with type 2 diabetes mellitus
Hiroi, N., Sue, M., Yoshihara, A., Ichijo, T., Yoshida-Hiroi, M., Higa, M., & Yoshino, G. (2010) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-2-71 · Cited by 12
Harman, E., Karadeniz, M., Biray, C., Zengi, A., Çetinkalp, Ş., Özgen, G., Saygılı, F., Berdeli, A., Gündüz, C., & Yılmaz, C. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345766 · Cited by 11
Ruiz, A., Michalopoulou, T., Megía, A., Näf, S., Simón‐Muela, I., Solano, E., Martínez, L., & Vendrell, J. J. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.13048 · Cited by 12
Gontarz-Nowak, K., Szklarz, M., Szychlińska, M., Matuszewski, W., & Bandurska-Stankiewicz, E. M. (2023) · Medicina · doi:10.3390/medicina59071234 · Cited by 10
Bilateral adrenal incidentaloma with subclinical hypercortisolemia: indications for surgery
Papierska, L., Ćwikła, J. B., Rabijewski, M., Glinicki, P., Otto, M., & Kasperlik-Zaluska, A. A. (2014) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.2347 · Cited by 10
Mintziori, G., Georgiou, T., Anagnostis, P. G., Adamidou, F., Efstathiadou, Z. A., Panagiotou, A., & Kita, M. D. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0630-1397 · Cited by 9
Parasiliti‐Caprino, M., Roux, A., Campioni, L., Procopio, M., Arata, S., Giannelli, J., Bollati, M., Bima, C., Lopez, C., Bioletto, F., et al. (2024) · Hypertension Research · doi:10.1038/s41440-024-01807-3 · Cited by 8
Herrera-Martínez, A. D., Román, Á. R., Corrales, E. P., Idrobo, C., Ramírez, P. A. P., Rojas‐Marcos, P. M., Lázaro, C. R., Marginean, D. L., & Castro, M. A. (2023) · Cancers · doi:10.3390/cancers15194735 · Cited by 9
Krzyżewska, K., Niemczuk, E., Myśliwiec, B. J., & Junik, R. (2017) · Endokrynologia Polska · doi:10.5603/ep.a2017.0034 · Cited by 8
Indications and Results of Surgery for Incidentally Found Adrenal Tumors
Meyer, A. A., & Behrend, M. (2006) · Urologia Internationalis · doi:10.1159/000093915 · Cited by 8
Torrecilla, N. B., Cano, A. M. G., Valderrábano, P., Tobar, A. Q., Escobar-Morreale, H. F., & Castro, M. A. (2023) · Endocrine · doi:10.1007/s12020-023-03396-6 · Cited by 7
Szychlińska, M., Rzeczkowska, M., Gontarz-Nowak, K., Matuszewski, W., & Bandurska-Stankiewicz, E. M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144612 · Cited by 7
Vasilev, V., Matrozova, J., Elenkova, A. P., & Zacharieva, S. (2013) · Open Medicine · doi:10.2478/s11536-013-0199-9 · Cited by 7
İmga, N. N., Topçuoğlu, C., Berker, D. S., & Turhan, T. (2018) · Archives of Medical Research · doi:10.1016/j.arcmed.2018.07.002 · Cited by 7
Castro, M. A., Corrales, E. P., Cano, A. M. G., Pinedo, M. M., Casals, G., Hanzu, F. A., Gómez-Bermejo, M. Á., Escobar-Morreale, H. F., & Valderrábano, P. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.11.009 · Cited by 7
Ersöz, F., Erbil, Y., Sarı, S., Salmaslıoğlu, A., İşsever, H., Aral, F., & Özarmağan, S. (2011) · World Journal of Surgery · doi:10.1007/s00268-011-1012-z · Cited by 7
Sexual dimorphism in benign adrenocortical tumours
Suntornlohanakul, O., Ronchi, C. L., Arlt, W., & Prete, A. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf088 · Cited by 6
Bleier, J., Pickovsky, J., Apter, S., Fishman, B., Dotan, Z., Tirosh, A., & Shlomai, G. (2021) · Clinical Endocrinology · doi:10.1111/cen.14651 · Cited by 6
Vassilopoulou‐Sellin, R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7241-5 · Cited by 6
Bleier, J., Shlomai, G., Fishman, B., Dotan, Z., Rosenzweig, B., & Tirosh, A. (2020) · Endocrine Practice · doi:10.4158/ep-2020-0111 · Cited by 5
Metabolic and cardiovascular impact of non-functioning adrenal adenomas: A clinical dilemma
Yener, S. (2013) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2013.02.005 · Cited by 5
Metadata
- Authors
- Reincke, M., Faßnacht, M., Väth, S., Mora, P., & Allolio, B.
- Affiliations
- University of Würzburg (DE)
- Venue
- Endocrine Research
- Publisher
- Informa UK Limited
- Published
- 1996-11
- Volume
- 22
- Issue
- 4
- Pages
- 757-761
- ISSN
- 0743-5800 (ISSN-L)
- 1532-4206
- OpenAlex
- W1904058160
- Cited by
- 133
- References
- 8
- Citations by year
- 2025: 3 · 2024: 4 · 2023: 13 · 2022: 6 · 2021: 1 · 2020: 8 · 2019: 4 · 2018: 7 · 2017: 6 · 2016: 2 · 2015: 6 · 2014: 5 · 2013: 2 · 2012: 7
- FWCI
- 2.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- adrenal incidentaloma, metabolic syndrome, hyperinsulinemia, insulin resistance, obesity, abdominal fat deposition, type 2 diabetes, insulin-like growth factor I, insulin-like growth factor II
- MeSH terms
- Adrenal Cortex Neoplasms, Body Constitution, Cell Division, Diabetes Mellitus, Type 2, Humans, Hyperinsulinism, Hypertension, Insulin, Insulin Resistance, Obesity, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review